Antibe Therapeutics Inc. – Trademark Portfolio
Entity Type: 03
Antibe Therapeutics Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include GOPIVEO and LEMBAYLI. The owner is based in Toronto, Ontario.
15 Prince Arthur Avenue
Toronto, Ontario M5R1B2 , CA
Showing of trademarks Trademarks
Trademark Classifications
Antibe Therapeutics Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Antibe Therapeutics Inc. have?
Antibe Therapeutics Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Antibe Therapeutics Inc. file in?
Antibe Therapeutics Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Antibe Therapeutics Inc.'s most well-known trademarks?
Antibe Therapeutics Inc.'s registered trademark portfolio includes well-known marks such as GOPIVEO and LEMBAYLI. These are among 2 currently registered trademarks in the portfolio.
What is Antibe Therapeutics Inc.'s trademark registration success rate?
Antibe Therapeutics Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.